drug protocol number

CT20/001/R

drug sponsor

KAIMRC

drug study

Ceftriaxone - Piperacillin Tazobactam - Azithromycin - Interferon β1-a - Hydrocortisone sodium suc... - Hydroxychloroquine - OSELTAMIVIR - Lopinavir-Ritonavir

drug trial site

NGHA-R

drug status

Ongoing

drug phase